Breathing Device for Orthostatic Hypotension (OH)

Sponsor
Alfredo Gamboa (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00962884
Collaborator
Vanderbilt University Medical Center (Other)
0
1
2
144
0

Study Details

Study Description

Brief Summary

The investigators will test whether breathing through an inspiratory resistance device will improve the ability to be upright and decrease blood pressure drops on standing in patients with orthostatic hypotension.

Condition or Disease Intervention/Treatment Phase
  • Device: Inspiratory Threshold Device (Res-Q-Gard ITD)
  • Device: Sham Inspiratory Threshold Device
N/A

Detailed Description

Orthostatic hypotension is commonly described, especially in an elderly population. Using data from a national hospital inpatient database, Shibao et al. have reported that the annual hospitalization rate for orthostatic hypotension was 233 per 100000 among patients older than 75 years. Orthostatic hypotension is associated with an increased risk of falls, increased risk of coronary heart disease and mortality.

Orthostatic hypotension is defined as a fall in systolic blood pressure of at least 20 mmHg within 3 minutes upon standing 3. Patients with orthostatic hypotension commonly experience lightheadedness or syncope. In normal individuals, changes in posture do not results in significant changes in blood pressure due to physiological compensation for the gravity-mediated pooling of blood in the lower limbs with upright posture. Unfortunately, in patients with impairments of the autonomic nervous system, one or more of these adaptive mechanisms fail, and an orthostatic fall in blood pressure results.

In this pilot study, we will test the hypothesis that breathing through an inspiratory resistance device will improve orthostatic tolerance and reduce orthostatic hypotension in patients with neurogenic orthostatic hypotension.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Assessment of Inspiratory Breathing Devices to Improve Orthostatic Tolerance in Neurogenic Orthostatic Hypotension
Study Start Date :
Dec 1, 2010
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: ITD breathing device

Breathing through the Res-Q-Gard ITD device from Advanced Circulatory Systems Inc.

Device: Inspiratory Threshold Device (Res-Q-Gard ITD)
Patient will breathe through this device attached to a mouthpiece during assessment of orthostatic tolerance.
Other Names:
  • Res-Q-Gard ITD device 7.0 (Ref:12-0463-000)
  • Sham Comparator: Sham Device

    Breathing device similar to active Res-Q-Gard device but with one-way resistance valve removed.

    Device: Sham Inspiratory Threshold Device
    Breathing through device similar to active device but with the one-way threshold valve removed.
    Other Names:
  • Res-Q-Gard device 7.0 (with active valve removed)
  • Outcome Measures

    Primary Outcome Measures

    1. Magnitude of drop in Systolic Blood Pressure during head-up tilt [1 min]

    Secondary Outcome Measures

    1. "Standing Time" tolerated with systolic blood pressure above 70 mmHg [10 min (max)]

    2. Symptom rating [10 min (max)]

    3. Hemodynamics (non-invasive) [10 min]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosed with neurogenic orthostatic hypotension by the Vanderbilt Autonomic Dysfunction Center

    • Decrease in systolic blood pressure ≥ 20 mmHg with position change from supine to standing (10 minutes)

    • Evidence of reproducibility suggestive of non-reversible nervous system origin for the orthostatic hypotension

    • Age between 18-80 years

    • Male and female subjects are eligible

    • Able and willing to provide informed consent

    Exclusion Criteria:
    • Overt cause for orthostatic hypotension (such as acute dehydration)

    • Inability to give, or withdrawal of, informed consent

    • Pregnant

    • Other factors which in the investigator's opinion would prevent the subject from completing the protocol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vanderbilt University Medical Center Nashville Tennessee United States 37232-2195

    Sponsors and Collaborators

    • Alfredo Gamboa
    • Vanderbilt University Medical Center

    Investigators

    • Principal Investigator: Satish R Raj, MD MSCI, Vanderbilt University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Alfredo Gamboa, Research Assistant Professor of Medicine, Vanderbilt University Medical Center
    ClinicalTrials.gov Identifier:
    NCT00962884
    Other Study ID Numbers:
    • 090600
    First Posted:
    Aug 20, 2009
    Last Update Posted:
    Nov 22, 2021
    Last Verified:
    Nov 1, 2021
    Keywords provided by Alfredo Gamboa, Research Assistant Professor of Medicine, Vanderbilt University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 22, 2021